868459108SUPERNUS PHARMACEUTICALS
CUSIP 868459108 · common stock
4 tracked investors held SUPERNUS PHARMACEUTICALS (868459108) at the end of Q3 2026, worth $18.3M in total. The largest holder was Bruce & Co, with 2.3% of its portfolio. Joel Greenblatt sold out of its position this quarter.
Holders · Q3 2026
4
New holders
0
Value held
$18.3M
Quarter-end price (est.)
$43.04
Investors holding 868459108 · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Bruce & Co Bruce & Co., Inc. | 2.33% | 200,000 | $8.6M | ADD+33.3% |
| Third Avenue Management Third Avenue Management LLC | 1.13% | 157,150 | $6.8M | ADD+2.9% |
| Chuck Royce Royce & Associates LP | 0.02% | 40,385 | $1.7M | ADD+2.2% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.05% | 27,842 | $1.2M | HOLD |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Joel Greenblatt | 0.00% | 7,422 | $345.2K | EXIT |